Recurium IP Holdings, LLC

Recurium IP Holding, LLC

Rakesh Kumar Sit

Kevin Duane Bunker

Peter Qinhua Huang

Joseph Robert Pinchman

Ahmed Abdi Samatar

Chad Daniel Hopkins

Deborah Helen Slee

Sayee Gajanan Hegde

Mehmet Kahraman

Sunny Abraham

Daniel Lee Severance

Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as cancer and tumors, as well as viral infections such as HIV.

Benzamide compounds

Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as cancer and tumors, as well as viral infections such as HIV. 

Compounds of Formula (I) are estrogen receptor alpha modulators, where the variables in Formula (I) are described in the disclosure. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions that are estrogen receptor alpha dependent and/or estrogen receptor alpha mediated, including conditions characterized by excessive cellular proliferation, such as breast cancer. 

Estrogen receptor modulators

Disclosed herein are spirocyclic compounds, together with pharmaceutical compositions and methods of ameliorating and/or treating a cancer described herein with one or more of the compounds described herein.

Spirocyclic compounds

Growing community of inventors

San Diego, CA, United States of America

Rakesh Kumar Sit